Cargando…
Incremental Costs and Cost Effectiveness of Intensive Treatment in Individuals with Type 2 Diabetes Detected by Screening in the ADDITION-UK Trial: An Update with Empirical Trial–Based Cost Data()
BACKGROUND: There is uncertainty about the cost effectiveness of early intensive treatment versus routine care in individuals with type 2 diabetes detected by screening. OBJECTIVES: To derive a trial-informed estimate of the incremental costs of intensive treatment as delivered in the Anglo-Danish-D...
Autores principales: | Laxy, Michael, Wilson, Edward C.F., Boothby, Clare E., Griffin, Simon J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086325/ https://www.ncbi.nlm.nih.gov/pubmed/29241888 http://dx.doi.org/10.1016/j.jval.2017.05.018 |
Ejemplares similares
-
How good are GPs at adhering to a pragmatic trial protocol in primary care? Results from the ADDITION-Cambridge cluster-randomised pragmatic trial
por: Laxy, Michael, et al.
Publicado: (2018) -
Cost-effectiveness of intensive multifactorial treatment compared with routine care for individuals with screen-detected Type 2 diabetes: analysis of the ADDITION-UK cluster-randomized controlled trial
por: Tao, L, et al.
Publicado: (2015) -
Incremental Cost of Prematurity by Week of Gestational Age
por: Walsh, Eileen M., et al.
Publicado: (2019) -
Estimating the impact of neonatal abstinence system interventions on Medicaid: an incremental cost analysis
por: López-Soto, Diana, et al.
Publicado: (2021) -
Incremental Net Benefit and Incremental Cost-Effectiveness Ratio of COVID-19 Vaccination Campaigns: Systematic Review of Cost-Effectiveness Evidence
por: Santoli, Giuseppe, et al.
Publicado: (2023)